|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CLYBL-ABCC4 (FusionGDB2 ID:17494) |
Fusion Gene Summary for CLYBL-ABCC4 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CLYBL-ABCC4 | Fusion gene ID: 17494 | Hgene | Tgene | Gene symbol | CLYBL | ABCC4 | Gene ID | 171425 | 10257 |
Gene name | citramalyl-CoA lyase | ATP binding cassette subfamily C member 4 | |
Synonyms | CLB | MOAT-B|MOATB|MRP4 | |
Cytomap | 13q32.3 | 13q32.1 | |
Type of gene | protein-coding | protein-coding | |
Description | citramalyl-CoA lyase, mitochondrial(3S)-malyl-CoA thioesterasebeta-methylmalate synthasecitrate lyase beta likecitrate lyase subunit beta-like protein, mitochondrialmalate synthase | multidrug resistance-associated protein 4MRP/cMOAT-related ABC transporterbA464I2.1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 4)canalicular multispecific organic anion transporter (ABC superfamily)multi-specific organic anion transporter | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q8N0X4 | O15439 | |
Ensembl transtripts involved in fusion gene | ENST00000376355, ENST00000444838, ENST00000376360, ENST00000376354, ENST00000339105, | ENST00000412704, ENST00000376887, ENST00000536256, ENST00000431522, ENST00000538287, ENST00000474158, | |
Fusion gene scores | * DoF score | 7 X 8 X 4=224 | 20 X 18 X 5=1800 |
# samples | 8 | 21 | |
** MAII score | log2(8/224*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(21/1800*10)=-3.09953567355091 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CLYBL [Title/Abstract] AND ABCC4 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CLYBL(100407025)-ABCC4(95696016), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CLYBL | GO:0070207 | protein homotrimerization | 29056341 |
Hgene | CLYBL | GO:0106064 | regulation of cobalamin metabolic process | 29056341 |
Tgene | ABCC4 | GO:0032310 | prostaglandin secretion | 25173977 |
Fusion gene breakpoints across CLYBL (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ABCC4 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | EC562134 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
Top |
Fusion Gene ORF analysis for CLYBL-ABCC4 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000376355 | ENST00000412704 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000376355 | ENST00000376887 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376355 | ENST00000536256 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376355 | ENST00000431522 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376355 | ENST00000538287 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376355 | ENST00000474158 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000444838 | ENST00000412704 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000444838 | ENST00000376887 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000444838 | ENST00000536256 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000444838 | ENST00000431522 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000444838 | ENST00000538287 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000444838 | ENST00000474158 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000376360 | ENST00000412704 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000376360 | ENST00000376887 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376360 | ENST00000536256 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376360 | ENST00000431522 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376360 | ENST00000538287 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376360 | ENST00000474158 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000376354 | ENST00000412704 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000376354 | ENST00000376887 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376354 | ENST00000536256 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376354 | ENST00000431522 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376354 | ENST00000538287 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000376354 | ENST00000474158 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000339105 | ENST00000412704 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-3CDS | ENST00000339105 | ENST00000376887 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000339105 | ENST00000536256 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000339105 | ENST00000431522 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000339105 | ENST00000538287 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
intron-intron | ENST00000339105 | ENST00000474158 | CLYBL | chr13 | 100407025 | + | ABCC4 | chr13 | 95696016 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CLYBL-ABCC4 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CLYBL-ABCC4 |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CLYBL | ABCC4 |
FUNCTION: Mitochondrial citramalyl-CoA lyase indirectly involved in the vitamin B12 metabolism (PubMed:29056341). Converts citramalyl-CoA into acetyl-CoA and pyruvate in the C5-dicarboxylate catabolism pathway (PubMed:29056341). The C5-dicarboxylate catabolism pathway is required to detoxify itaconate, a vitamin B12-poisoning metabolite (PubMed:29056341). Also acts as a malate synthase in vitro, converting glyoxylate and acetyl-CoA to malate (PubMed:29056341, PubMed:24334609). Also displays malyl-CoA thioesterase activity (PubMed:29056341). Also acts as a beta-methylmalate synthase in vitro, by mediating conversion of glyoxylate and propionyl-CoA to beta-methylmalate (PubMed:24334609, PubMed:29056341). Also has very weak citramalate synthase activity in vitro (PubMed:24334609, PubMed:29056341). {ECO:0000269|PubMed:24334609, ECO:0000269|PubMed:29056341}. | FUNCTION: ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds and xenobiotics from cells. Transports a range of endogenous molecules that have a key role in cellular communication and signaling, including cyclic nucleotides such as cyclic AMP (cAMP) and cyclic GMP (cGMP), bile acids, steroid conjugates, urate, and prostaglandins (PubMed:11856762, PubMed:12883481, PubMed:12523936, PubMed:12835412, PubMed:15364914, PubMed:15454390, PubMed:16282361, PubMed:17959747, PubMed:18300232, PubMed:26721430). Mediates the ATP-dependent efflux of glutathione conjugates such as leukotriene C4 (LTC4) and leukotriene B4 (LTB4) too. The presence of GSH is necessary for the ATP-dependent transport of LTB4, whereas GSH is not required for the transport of LTC4 (PubMed:17959747). Mediates the cotransport of bile acids with reduced glutathione (GSH) (PubMed:12883481, PubMed:12523936, PubMed:16282361). Transports a wide range of drugs and their metabolites, including anticancer, antiviral and antibiotics molecules (PubMed:11856762, PubMed:12105214, PubMed:15454390, PubMed:18300232, PubMed:17344354). Confers resistance to anticancer agents such as methotrexate (PubMed:11106685). {ECO:0000269|PubMed:11106685, ECO:0000269|PubMed:11856762, ECO:0000269|PubMed:12105214, ECO:0000269|PubMed:12523936, ECO:0000269|PubMed:12835412, ECO:0000269|PubMed:12883481, ECO:0000269|PubMed:15364914, ECO:0000269|PubMed:15454390, ECO:0000269|PubMed:16282361, ECO:0000269|PubMed:17344354, ECO:0000269|PubMed:17959747, ECO:0000269|PubMed:18300232, ECO:0000269|PubMed:26721430}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CLYBL-ABCC4 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for CLYBL-ABCC4 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CLYBL-ABCC4 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CLYBL-ABCC4 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ABCC4 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Tgene | ABCC4 | C0009241 | Cognition Disorders | 1 | CTD_human |
Tgene | ABCC4 | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Tgene | ABCC4 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Tgene | ABCC4 | C0013146 | Drug abuse | 1 | CTD_human |
Tgene | ABCC4 | C0013170 | Drug habituation | 1 | CTD_human |
Tgene | ABCC4 | C0013221 | Drug toxicity | 1 | CTD_human |
Tgene | ABCC4 | C0013222 | Drug Use Disorders | 1 | CTD_human |
Tgene | ABCC4 | C0014175 | Endometriosis | 1 | CTD_human |
Tgene | ABCC4 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Tgene | ABCC4 | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Tgene | ABCC4 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | ABCC4 | C0038580 | Substance Dependence | 1 | CTD_human |
Tgene | ABCC4 | C0038586 | Substance Use Disorders | 1 | CTD_human |
Tgene | ABCC4 | C0041755 | Adverse reaction to drug | 1 | CTD_human |
Tgene | ABCC4 | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Tgene | ABCC4 | C0269102 | Endometrioma | 1 | CTD_human |
Tgene | ABCC4 | C0342257 | Complications of Diabetes Mellitus | 1 | CTD_human |
Tgene | ABCC4 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Tgene | ABCC4 | C0740858 | Substance abuse problem | 1 | CTD_human |
Tgene | ABCC4 | C1510472 | Drug Dependence | 1 | CTD_human |
Tgene | ABCC4 | C4316881 | Prescription Drug Abuse | 1 | CTD_human |